UB Paderborn / Katalog / Suche / in CDI

Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database

Head & neck, 2014-05, Vol.36 (5), p.694-701

2014

Link zum Volltext

Verfügbarkeit prüfen

Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation

The Laryngoscope, 2016-12, Vol.126 (12), p.2733-2738

2016

Link zum Volltext

Verfügbarkeit prüfen

Response to “Comparison between Organ Preservation Surgery and Radiation in Early Supraglottic Carcinoma Is Limited by Bias”

Otolaryngology-head and neck surgery, 2014-07, Vol.151 (1), p.182-183

2014

Link zum Volltext

Verfügbarkeit prüfen

Survival Differences between Organ Preservation Surgery and Definitive Radiotherapy in Early Supraglottic Squamous Cell Carcinoma

Otolaryngology-head and neck surgery, 2014-02, Vol.150 (2), p.237-244

2014

Link zum Volltext

Verfügbarkeit prüfen

Oropharyngeal cancer: current understanding and management

Current opinion in otolaryngology & head and neck surgery, 2009-04, Vol.17 (2), p.88-94

2009

Link zum Volltext

Verfügbarkeit prüfen

Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011

The Laryngoscope, 2017-05, Vol.127 (5), p.1087-1092

2017

Link zum Volltext

Verfügbarkeit prüfen

Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1)

Melanoma management, 2019-06, Vol.6 (2), p.MMT19-MMT19

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns of melanoma by BRAF mutation status in the USA from 2011 to 2017: a retrospective cohort study

Melanoma management, 2019-12, Vol.6 (4), p.MMT31-MMT31

2019

Link zum Volltext

Verfügbarkeit prüfen

Combined surgery and radiation improves survival of tonsil squamous cell cancers

Oncotarget, 2017-12, Vol.8 (68), p.112442-112450

2017

Link zum Volltext

Verfügbarkeit prüfen

Palatal reconstruction

Current opinion in otolaryngology & head and neck surgery, 2012-08, Vol.20 (4), p.225-230

2012

Link zum Volltext

Verfügbarkeit prüfen

An open-label, multicenter study investigating RP3 oncolytic immunotherapy in combination with first- or second-line systemic atezolizumab and bevacizumab therapy in patients with locally advanced unresectable or metastatic hepatocellular carcinoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS4178-TPS4178

2023

Link zum Volltext

Verfügbarkeit prüfen

Determining the protein drug release characteristics and cell adhesion to a PLLA or PLGA biodegradable polymer membrane

Journal of biomedical materials research. Part A, 2010-07, Vol.94A (1), p.27-37

2010

Link zum Volltext

Verfügbarkeit prüfen

An open-label, multicenter study investigating RP3 oncolytic immunotherapy in combination with first- or second-line systemic atezolizumab and bevacizumab therapy in patients with locally advanced unresectable or metastatic hepatocellular carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS623-TPS623

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns of malignant melanoma in the United States from 2011 to 2016: a retrospective cohort study

Current medical research and opinion, 2020-01, Vol.36 (1), p.63-72

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns of malignant melanoma in the United States in 2011-2016: A retrospective cohort study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21633-e21633

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase 2, open-label, multicenter study investigating efficacy and safety of RP3 oncolytic immunotherapy combined with other therapies in patients with locoregionally advanced or recurrent squamous cell carcinoma of the head and neck

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS6106-TPS6106

2023

Link zum Volltext

Verfügbarkeit prüfen

Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

Leukemia & lymphoma, 2020-07, Vol.61 (9), p.2103-2112

2020

Link zum Volltext

Verfügbarkeit prüfen

Subgroup Analysis: Efficacy and Safety of Panobinostat in Combination with SC Bortezomib and Oral Dexamethasone in Multiple Myeloma Patients with Lenalidomide-Refractory Disease

Blood, 2021-11, Vol.138 (Supplement 1), p.3759-3759

2021

Link zum Volltext

Verfügbarkeit prüfen

Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Results of an Interim Analysis

Blood, 2021-11, Vol.138 (Supplement 1), p.2456-2456

2021

Link zum Volltext

Verfügbarkeit prüfen

TEMPO: A Phase 2, Randomized, Open-Label, 2-Arm Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Subjects with Indolent Non Hodgkin Lymphoma (iNHL)

Blood, 2021-11, Vol.138 (Supplement 1), p.3545-3545

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study

Advances in therapy, 2019-11, Vol.36 (11), p.3017-3029

2019

Link zum Volltext

Verfügbarkeit prüfen

Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma

Leukemia & lymphoma, 2020-09, Vol.61 (11), p.2767-2770

2020

Link zum Volltext

Verfügbarkeit prüfen

Durability of complete response after blinatumomab therapy for refractory/relapsed aggressive B-cell non-Hodgkin lymphoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e19041-e19041

2019

Link zum Volltext

Verfügbarkeit prüfen

Sentinel node biopsy in lieu of neck dissection for staging oral cancer

JAMA otolaryngology-- head & neck surgery, 2013-08, Vol.139 (8), p.779

2013

Link zum Volltext

Verfügbarkeit prüfen

Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways

Supportive care in cancer, 2013-10, Vol.21 (10), p.2825-2833

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database

Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation

Response to “Comparison between Organ Preservation Surgery and Radiation in Early Supraglottic Carcinoma Is Limited by Bias”

Survival Differences between Organ Preservation Surgery and Definitive Radiotherapy in Early Supraglottic Squamous Cell Carcinoma

Oropharyngeal cancer: current understanding and management

Subsite variation in survival of oropharyngeal squamous cell carcinomas 2004 to 2011

Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1)

Treatment patterns of melanoma by BRAF mutation status in the USA from 2011 to 2017: a retrospective cohort study

Combined surgery and radiation improves survival of tonsil squamous cell cancers

Palatal reconstruction

An open-label, multicenter study investigating RP3 oncolytic immunotherapy in combination with first- or second-line systemic atezolizumab and bevacizumab therapy in patients with locally advanced unresectable or metastatic hepatocellular carcinoma

Determining the protein drug release characteristics and cell adhesion to a PLLA or PLGA biodegradable polymer membrane

An open-label, multicenter study investigating RP3 oncolytic immunotherapy in combination with first- or second-line systemic atezolizumab and bevacizumab therapy in patients with locally advanced unresectable or metastatic hepatocellular carcinoma

Treatment patterns of malignant melanoma in the United States from 2011 to 2016: a retrospective cohort study

Treatment patterns of malignant melanoma in the United States in 2011-2016: A retrospective cohort study

A phase 2, open-label, multicenter study investigating efficacy and safety of RP3 oncolytic immunotherapy combined with other therapies in patients with locoregionally advanced or recurrent squamous cell carcinoma of the head and neck

Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

Subgroup Analysis: Efficacy and Safety of Panobinostat in Combination with SC Bortezomib and Oral Dexamethasone in Multiple Myeloma Patients with Lenalidomide-Refractory Disease

Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Results of an Interim Analysis

TEMPO: A Phase 2, Randomized, Open-Label, 2-Arm Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Subjects with Indolent Non Hodgkin Lymphoma (iNHL)

Clinicians’ Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study

Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma

Durability of complete response after blinatumomab therapy for refractory/relapsed aggressive B-cell non-Hodgkin lymphoma

Sentinel node biopsy in lieu of neck dissection for staging oral cancer

Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways

Suchergebnisse filtern